Do you know which pharma news websites cover clinical trials for mental health treatments?
Websites that cover clinical trials for mental health treatments provide valuable insights into the latest developments, results, and innovations in therapies for mental health conditions. Here are some of the top websites focusing on this area:
1. PhRMA (Pharmaceutical Research and Manufacturers of America) – PhRMA released a report covering 163 medicines in development targeting common mental illnesses, all of which are in clinical trials or awaiting review by the U.S. Food and Drug Administration (FDA)[1].
2. Pharma News Intel – Discusses the importance of diversity and inclusion in clinical trials, which is key to advancing health equity. This is particularly relevant for mental health treatments, as diverse clinical trial participation ensures the efficacy and safety of new treatments across different demographics[2].
3. ClinicalTrials.gov – An official website of the U.S. Department of Health and Human Services, ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world, including those for mental health treatments. It offers comprehensive information on clinical trials, including their status, location, and results[3].
4. PR Newswire (Gilgamesh Pharmaceuticals) – Gilgamesh Pharmaceuticals, a biotechnology company, is developing a portfolio of rapid-acting and durable treatments for depression and other mental health conditions. The company raised $39 million in Series B funding to advance two programs into clinical trials[4].
5. UCSF News (University of California, San Francisco) – Reports on the latest trial results of MDMA-assisted therapy for patients with PTSD, offering hope for new mental health treatments. The trial’s sponsor, MAPS Public Benefit Corp., plans to submit its drug application to the FDA[5].
6. PharmaTimes – Covers Small Pharma’s initiation of a phase 1 mental health therapy trial. The study is a blinded, placebo-controlled, randomized, and dose-escalating study being conducted at MAC Clinical Research in Manchester, focusing on new therapies for mental health[6].
7. Johns Hopkins Center for Psychedelic and Consciousness Research – Leads the way in exploring innovative treatments using psilocybin for mental health conditions. The center has conducted several studies showing the potential of psychedelics to treat a wide range of mood and substance disorders[7].
These websites are essential for professionals, researchers, and anyone interested in the latest clinical trial activities and developments in treatments for mental health conditions. They provide timely updates, in-depth analyses, and comprehensive coverage of the trials that shape the future of mental health care.
Citations:
[1] https://phrma.org/Blog/New-Report-More-than-160-medicines-in-development-for-mental-illness
[2] https://pharmanewsintel.com/features/clinical-trial-diversity-inclusion-key-to-advancing-health-equity
[3] https://clinicaltrials.gov
[4] https://www.prnewswire.com/news-releases/gilgamesh-pharmaceuticals-raises-39-million-series-b-to-advance-mental-health-treatments-301704097.html
[5] https://www.ucsf.edu/news/2023/09/426116/mdmas-latest-trial-results-offer-hope-for-patients-ptsd
[6] https://pharmatimes.com/news/small_pharma_begins_phase_1_mental_health_therapy_trial_1486736/
[7] https://www.hopkinsmedicine.org/psychiatry/research/psychedelics-research
[8] https://www.otsuka-us.com/news/otsuka-pharmaceutical-acquire-mindset-pharma-strengthens-pipeline-area-psychiatric-and